# Evaluation of the Standard Catheter-directed Thrombolysis Effectiveness in Intermediate-High-Risk Pulmonary Embolism Patients

> **NCT06487052** · NA · RECRUITING · sponsor: **Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health** · enrollment: 100 (estimated)

## Conditions studied

- Pulmonary Embolism Acute

## Interventions

- **COMBINATION_PRODUCT:** Standard Catheter-Directed Low Dose Thrombolysis
- **DRUG:** Standard Anticoagulation

## Key facts

- **NCT ID:** NCT06487052
- **Lead sponsor:** Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-10
- **Primary completion:** 2027-01
- **Final completion:** 2027-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06487052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06487052, "Evaluation of the Standard Catheter-directed Thrombolysis Effectiveness in Intermediate-High-Risk Pulmonary Embolism Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06487052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*